Press Release

NFκB Reporter 293T and A549 Stable Cell Lines

Redwood City, Calif. January 5, 2005—Panomics, Inc. introduces NFκB Reporter 293T and A549 Stable Cell Lines as reproducible, ready-to-use evaluation devices for in vivo drug screening, characterization of growth factors and extracellular stimuli as well as assessment of signaling pathway convergence upon NFκB.